Stuart Thomson
Impact in
- Oncology top 2%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer Research top 5%
Papers in
-
- Ubiquitin and proteasome pathways 10
- Genomics and Chromatin Dynamics 5
- Oncology 16
- HER2/EGFR in Cancer Research 4
- Peptidase Inhibition and Analysis 4
- Co-authors
- Louis C. Mahadevan (8 shared papers)John D. Haley (11 shared papers)Alison L. Clayton (4 shared papers)Filippo Petti (5 shared papers)Neil W. Gibson (4 shared papers)Kenneth K. Iwata (5 shared papers)Elizabeth Buck (6 shared papers)David Epstein (6 shared papers)
- Journals
- Cancer Research (4 papers)Clinical & Experimental Metastasis (4 papers)Molecular Cell (3 papers)Molecular Cancer Therapeutics (3 papers)Transactions of the ASABE (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Stuart Thomson
59 papers receiving 4.3k citations
Stuart Thomson's Hit Papers
Peers
Comparison fields: 5 of 152
- Oncology 1.1k
- Cancer Research 533
- Molecular Biology 2.4k
- Pulmonary and Respiratory Medicine 627
- Cell Biology 345
Countries citing papers authored by Stuart Thomson
This map shows the geographic impact of Stuart Thomson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Thomson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Thomson more than expected).
Fields of papers citing papers by Stuart Thomson
This network shows the impact of papers produced by Stuart Thomson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Thomson. The network helps show where Stuart Thomson may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart Thomson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epithelial to Mesenchymal Transition Is a Determinant of Sensitivity of Non–Small-Cell Lung Carcinoma Cell Lines and Xenografts to Epidermal Growth Factor Receptor Inhibition Hit paper breakdown → | 2005 | 554 |
| 2 | 2003 | 425 | |
| 3 | 1999 | 397 | |
| 4 | 2006 | 351 | |
| 5 | 2005 | 195 | |
| 6 | 1999 | 194 | |
| 7 | 2010 | 186 | |
| 8 | 2001 | 182 | |
| 9 | 2008 | 172 | |
| 10 | 2008 | 166 | |
| 11 | 2008 | 162 | |
| 12 | 1996 | 156 | |
| 13 | 2001 | 111 | |
| 14 | 2003 | 104 | |
| 15 | 2005 | 92 | |
| 16 | 1995 | 87 | |
| 17 | 2001 | 82 | |
| 18 | 2003 | 75 | |
| 19 | 2004 | 67 | |
| 20 | 2011 | 53 |
About Stuart Thomson
Stuart Thomson is a scholar working on Molecular Biology, Oncology, Materials Chemistry, Pulmonary and Respiratory Medicine and Biomedical Engineering, having authored 61 papers that have together received 4.4k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (10 papers), Lung Cancer Treatments and Mutations (6 papers), Micro and Nano Robotics (5 papers), Genomics and Chromatin Dynamics (5 papers), Chemical Synthesis and Characterization (4 papers), Zeolite Catalysis and Synthesis (4 papers), HER2/EGFR in Cancer Research (4 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (533 citations), Molecular Biology (2.4k citations), Pulmonary and Respiratory Medicine (627 citations) and Cell Biology (345 citations). Stuart Thomson has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Louis C. Mahadevan, John D. Haley, Alison L. Clayton, Filippo Petti, Neil W. Gibson, Kenneth K. Iwata, Elizabeth Buck, David Epstein, Catherine A. Hazzalin and Eric Brown. Their work appears in journals such as Cancer Research, Clinical & Experimental Metastasis, Molecular Cell, Molecular Cancer Therapeutics and Transactions of the ASABE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.